pharmacie et médicaments – Abaissement du plafond des remises sur les médicaments génériques

This written question asks about lowering the rebate ceiling for generic medicines in France. It seeks to understand the potential impact on pharmaceutical costs and accessibility. The question concerns the pharmaceutical industry and healthcare providers. It may affect patient access to affordable generic drugs and the financial sustainability of the healthcare system.